These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16105039)

  • 1. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis.
    Plank C; Hartner A; Klanke B; Geissler B; Porst M; Amann K; Hilgers KF; Rascher W; Dötsch J
    Kidney Int; 2005 Sep; 68(3):1086-95. PubMed ID: 16105039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adrenomedullin on the glomerular adrenomedullin system in a rat model of anti-thy1 glomerulonephritis.
    Geissler B; Plank C; Hartner A; Amann K; Struwe FG; Hilgers KF; Rascher W; Dötsch J
    Nephron Exp Nephrol; 2010; 115(3):e80-8. PubMed ID: 20431304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
    Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
    Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
    Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
    Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
    Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
    Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
    Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu Snake Venom glomerulonephritis.
    Dimmler A; Haas CS; Cho S; Hattler M; Forster C; Peters H; Schöcklmann HO; Amann K
    Diagn Mol Pathol; 2003 Jun; 12(2):108-17. PubMed ID: 12766616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
    Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
    Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
    Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
    J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis.
    Matsumoto M; Fujimoto S; Iwatsubo S; Sato Y; Hara S; Kitamura K; Eto T
    Clin Exp Nephrol; 2004 Dec; 8(4):316-21. PubMed ID: 15619030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis.
    Monkawa T; Pippin J; Yo Y; Kopp JB; Alpers CE; Shankland SJ
    Nephron Exp Nephrol; 2006; 102(1):e8-18. PubMed ID: 16179805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.
    Canaan-Kühl S; Ostendorf T; Zander K; Koch KM; Floege J
    Kidney Int; 1998 May; 53(5):1143-51. PubMed ID: 9573528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antisense monocyte chemoattractant protein-1 (MCP-1) in a rat model of mesangial proliferative glomerulonephritis.
    Liu H; Zhang XP; Yi ZW
    Ren Fail; 2013; 35(10):1418-28. PubMed ID: 23991758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
    Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
    Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.